Zdrowie i gospodarka · 29/02/2012
FDA Withdraws Hearing Requests for Hydroxyzine Hydrochloride and Hydroxyzine Pamoate Prescription Drugs
The FDA has withdrawn all outstanding hearing requests for prescription drugs containing hydroxyzine hydrochloride or hydroxyzine pamoate, making it unlawful to ship these products in interstate commerce after a specified date